Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. - Wikidata - awgldk - TriplyDB

Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.

Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.

http://www.wikidata.org/entity/Q43032172

about

Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection Metabolic factors and chronic hepatitis C: a complex interplay Female gender in the setting of liver transplantation Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis.The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic Patients Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases Reproductive status is associated with the severity of fibrosis in women with hepatitis C.Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women.Subgroup differences in response to 8 weeks of ledipasvir/sofosbuvir for chronic hepatitis C Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study.How sex and age affect immune responses, susceptibility to infections, and response to vaccination Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.Predictive factors associated with hepatitis C antiviral therapy response.Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study The impact of host factors on management of hepatitis C virus.Female Sex Hormones Pattern and Its Relation to Disease Severity and Treatment in Pre- and Postmenopausal Patients with Chronic Hepatitis C Virus (Genotype 4) Infection Baseline serum cholesterol is associated with a response to pegylated interferon alfa-2b and ribavirin therapy for chronic hepatitis C genotype 2.Symptomatic menopausal transition increases the risk of new-onset depressive disorder in later life: a nationwide prospective cohort study in Taiwan.Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies Translating pharmacogenetics into clinical practice: interleukin (IL)28B and inosine triphosphatase (ITPA) polymophisms in hepatitis C virus (HCV) infection.Current understanding of insulin resistance in hepatitis C.Metabolic alterations and chronic hepatitis C: treatment strategies.Influence of age and gender before and after liver transplantation.Sex hormones and HCV: an unresolved mystery.Psychological, lifestyle and social predictors of hepatitis C treatment response: a systematic review.Review article: the management of cirrhosis in women.Sexual dimorphism in immunity: improving our understanding of vaccine immune responses in men.Cytokines and HCV-related autoimmune disorders.Hepatitis C Infection in the Elderly.Why do I treat my patients with mild hepatitis C?Use of antimüllerian hormone to predict the menopausal transition in HIV-infected women.The role played by gender in viral hepatitis.Natural history and management of hepatitis C: does sex play a role?The impact of antihyperlipidemic drugs on the viral load of patients with chronic hepatitis C infection: a meta-analysis.Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis.Liver disease in menopause.Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients.Prediction of a favorable clinical course in hepatitis C virus carriers with persistently normal serum alanine aminotransferase levels: A long-term follow-up study.Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis.Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C.

P2860

Q26830844-05943F35-D1EB-4646-BAE1-71C940684A8A Q27011787-38D083EE-91F4-4598-827A-9A02213B0CFA Q28087784-689965C2-1C1D-4B57-87D9-269388983435 Q30402192-7BD03FE9-8DF7-4C44-8E48-D3C7612C7CDC Q33844403-EA50FB90-90FB-42F1-B8D1-24AE92331674 Q33997400-0C810EEA-D948-4E0E-8A58-9DF0DEDB2EDB Q34412627-750125F4-959B-4B66-ADE3-0AA9FF552425 Q34589830-B6C71583-6E44-4E37-AE1F-2C91B89EE254 Q35072099-EDA98ACE-A4E4-4EF2-894B-722043E27D33 Q35249648-3822B984-464B-4675-A2FC-994B55310301 Q35527150-A8ABF0E0-BF42-4F61-81D3-78CDA3F57D2E Q35668307-2021E32E-5376-41DD-A73F-33C527413437 Q35790397-2A2F10A3-3229-4241-BAEB-78427ABC70C0 Q35832850-F18749E2-4B2A-4BEE-AEB2-E8FF1B415A19 Q35990066-75BB6679-0829-4F4C-BEBC-2FF3B032FA84 Q36112618-81C90879-2BB0-4264-86D3-36842A0FE67E Q36410947-7111A93E-E440-47E3-8203-028C674B4618 Q36721136-A09C2C42-39FE-4227-A618-FE2BBB94027B Q36761430-7BD7DA17-804C-4764-92E8-A8F849B91E59 Q37879701-0927D72E-0532-479E-8298-89EED73E5F28 Q37903853-79335C93-291F-4253-AF8A-7BAF16A765E4 Q37924816-8244C4DB-6FEC-4817-A616-33F83284044B Q38061619-C9F43531-30B9-4B85-A926-50A0D310A273 Q38069609-DB29E880-5579-4FE3-B38F-6701A8171BFC Q38098579-895DA6C9-C784-46D4-BC6A-82C1671BDE34 Q38255043-E688A04C-7ACD-43B2-902E-1367F7DAD8AD Q38256290-5ABD16B1-11A5-40E1-935A-91D1129B3A34 Q38266253-103ED6F3-B567-4AA6-AE5B-24FDF58FEAA4 Q38501726-A8D05929-5839-4B7B-99A6-0884F3B49546 Q38685564-268AAF1F-C8EF-418C-A2B4-9A1BA9C3A758 Q39544986-DBB8FBA0-EB0F-4A02-BA49-434BCAF5CAA1 Q42202432-56E28308-CBE9-4456-98DC-6E03D498EA52 Q42208880-839B4C2C-CE59-41F7-809C-EEF1DE4B03AE Q42211503-8594E56E-806B-4D03-A1BF-FA1FDA0BBAD2 Q42259157-5F20FBE0-4378-44AB-968D-D5F68E027927 Q42359764-5A424522-266C-43DB-ABF0-8AB50A61311A Q42977889-101C9660-1087-4508-82A3-F8D1CF9E8B9C Q45354798-8AA6A248-C95B-4479-AF3E-77AC79D76924 Q46772423-ECF54E9B-123F-4E84-985A-3CE2BAB2B5E1 Q50551487-39FADDC5-E9B1-459D-BDE2-7E595835C775

P2860

Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.

http://www.wikidata.org/entity/Q43032172

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Early menopause is associated ...... omen with chronic hepatitis C.

@en

Early menopause is associated ...... omen with chronic hepatitis C.

@nl

type

label

Early menopause is associated ...... omen with chronic hepatitis C.

@en

Early menopause is associated ...... omen with chronic hepatitis C.

@nl

prefLabel

Early menopause is associated ...... omen with chronic hepatitis C.

@en

Early menopause is associated ...... omen with chronic hepatitis C.

@nl

P1433

Q43032172-7C9A48F7-A881-4FF7-A952-3710E1011428

P1476

Q43032172-56D41C73-73C2-426D-9A77-97575591E2EF

P2093

Q43032172-2A5DA151-2E91-40BE-8774-9F13AFD48D6E

Q43032172-2F7AD8EF-F96B-4949-8ED3-EA248D95ED26

Q43032172-376C26E9-B6D9-41CB-8A1A-A50716D60378

Q43032172-515190E2-95EC-4F82-994E-E6B5C17EF9E4

Q43032172-5A44DD9D-5052-491E-885F-53156F87EDB2

Q43032172-70F42410-6834-443D-89A4-FBC4C5339584

Q43032172-71839BA9-8286-43F0-9873-99DE5B3D5B3C

Q43032172-781EE50C-5760-4111-A33D-1C116962D0D3

Q43032172-93DD1DB5-DC88-4970-81A0-071EF89EABE4

Q43032172-93E9A37D-C9D7-49D1-8453-7C9AC96776A1

P304

Q43032172-A02BAF1E-6AFC-425B-9D5A-22F613F7388D

P31

Q43032172-6AFCBDBE-74FC-4448-874F-D763CE6BC530

P356

Q43032172-DEF54F44-FBA1-4C9B-880C-2527E8D638E8

P407

Q43032172-036AF89D-2116-4DF8-B357-CE71E8C23A61

P433

Q43032172-4C2BE442-171B-4F97-AAE1-EB05FEF366D5

P478

Q43032172-DADFDABE-9BEA-4AF7-A0CC-986F887697D3

P50

Q43032172-39D00C45-965E-46EC-AD86-6757157EF155

Q43032172-5B86DE67-03FA-4FB9-9A47-CE55752B5E95

Q43032172-A411C7F2-607B-47D9-8519-1F434FA5E1C8

P577

Q43032172-FC519B39-866F-4B34-A127-ED79DF089DAB

P5875

Q43032172-30D7D835-86F6-4C39-9E4B-668ED9B5A2FB

P698

Q43032172-8D42AE80-939F-4C7F-AAA3-4CE7621A7568

P356

J.GASTRO.2010.12.027

P1433

Gastroenterology

P1476

Early menopause is associated ...... omen with chronic hepatitis C.

@en

P2093

Aimilia Karampatou

http://www.w3.org/2001/XMLSchema#string

Alessandro Antonelli

http://www.w3.org/2001/XMLSchema#string

Amalia Graziosi

http://www.w3.org/2001/XMLSchema#string

Anna Ferrari

http://www.w3.org/2001/XMLSchema#string

Antonio Francavilla

http://www.w3.org/2001/XMLSchema#string

Barbara Lei

http://www.w3.org/2001/XMLSchema#string

Calogero Cammà

http://www.w3.org/2001/XMLSchema#string

Gloria Taliani

http://www.w3.org/2001/XMLSchema#string

Luisa Losi

http://www.w3.org/2001/XMLSchema#string

Maria Rendina

http://www.w3.org/2001/XMLSchema#string

P304

818-829

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2010.12.027

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

140

http://www.w3.org/2001/XMLSchema#string

P50

Salvatore Petta

P577

2010-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49692572

http://www.w3.org/2001/XMLSchema#string

P698

21167831

http://www.w3.org/2001/XMLSchema#string